229 related articles for article (PubMed ID: 21072045)
1. A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.
Chen SH; Yang W; Fan Y; Stocco G; Crews KR; Yang JJ; Paugh SW; Pui CH; Evans WE; Relling MV
Leukemia; 2011 Jan; 25(1):66-74. PubMed ID: 21072045
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.
Ben Tanfous M; Sharif-Askari B; Ceppi F; Laaribi H; Gagné V; Rousseau J; Labuda M; Silverman LB; Sallan SE; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Clin Cancer Res; 2015 Jan; 21(2):329-34. PubMed ID: 24907114
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.
Abaji R; Gagné V; Xu CJ; Spinella JF; Ceppi F; Laverdière C; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Oncotarget; 2017 Jul; 8(27):43752-43767. PubMed ID: 28574850
[TBL] [Abstract][Full Text] [Related]
5.
Mootoosamy C; Kondyli M; Serfaty SA; Tremblay DÉ; Gagné V; Ribère M; Laverdière C; Leclerc JM; Sinnett D; Tran TH; Krajinovic M
Pharmacogenomics; 2023 Mar; 24(4):199-206. PubMed ID: 36946317
[TBL] [Abstract][Full Text] [Related]
6. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
Chen SH
Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
Kang SM; Rosales JL; Meier-Stephenson V; Kim S; Lee KY; Narendran A
Oncogene; 2017 Oct; 36(42):5910-5913. PubMed ID: 28650467
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase.
Hlozkova K; Pecinova A; Alquezar-Artieda N; Pajuelo-Reguera D; Simcikova M; Hovorkova L; Rejlova K; Zaliova M; Mracek T; Kolenova A; Stary J; Trka J; Starkova J
BMC Cancer; 2020 Jun; 20(1):526. PubMed ID: 32503472
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.
Fernandez CA; Smith C; Yang W; Mullighan CG; Qu C; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Karol SE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
Blood; 2015 Jul; 126(1):69-75. PubMed ID: 25987655
[TBL] [Abstract][Full Text] [Related]
11. HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway.
Lee JK; Kang S; Wang X; Rosales JL; Gao X; Byun HG; Jin Y; Fu S; Wang J; Lee KY
Blood; 2019 May; 133(20):2222-2232. PubMed ID: 30819925
[TBL] [Abstract][Full Text] [Related]
12. Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia.
Nielsen RL; Wolthers BO; Helenius M; Albertsen BK; Clemmensen L; Nielsen K; Kanerva J; Niinimäki R; Frandsen TL; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Aytan-Aktug D; Liu HC; Möricke A; Samarasinghe S; van der Sluis IM; Stanulla M; Tulstrup M; Yadav R; Zapotocka E; Schmiegelow K; Gupta R
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e628-e636. PubMed ID: 35226426
[TBL] [Abstract][Full Text] [Related]
13. Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.
Salzer W; Bostrom B; Messinger Y; Perissinotti AJ; Marini B
Leuk Lymphoma; 2018 Aug; 59(8):1797-1806. PubMed ID: 29045165
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.
Chen SH; Pei D; Yang W; Cheng C; Jeha S; Cox NJ; Evans WE; Pui CH; Relling MV
Clin Pharmacol Ther; 2010 Aug; 88(2):191-6. PubMed ID: 20592726
[TBL] [Abstract][Full Text] [Related]
15. Asparaginase in acute lymphoblastic leukemia.
Kawedia JD; Rytting ME
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S14-7. PubMed ID: 25486949
[TBL] [Abstract][Full Text] [Related]
16. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.
Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H
Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
Liu C; Yang W; Devidas M; Cheng C; Pei D; Smith C; Carroll WL; Raetz EA; Bowman WP; Larsen EC; Maloney KW; Martin PL; Mattano LA; Winick NJ; Mardis ER; Fulton RS; Bhojwani D; Howard SC; Jeha S; Pui CH; Hunger SP; Evans WE; Loh ML; Relling MV
J Clin Oncol; 2016 Jun; 34(18):2133-40. PubMed ID: 27114598
[TBL] [Abstract][Full Text] [Related]
19. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
Ylikangas P; Mononen I
Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
[TBL] [Abstract][Full Text] [Related]
20. Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia.
Alachkar H; Fulton N; Sanford B; Malnassy G; Mutonga M; Larson RA; Bloomfield CD; Marcucci G; Nakamura Y; Stock W
Pharmacogenomics J; 2017 Jun; 17(3):274-279. PubMed ID: 27019981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
